{"entity":{"type":"insider","cik":"0001442675","url":"/insider/0001442675","json_url":"/insider/0001442675.json","name":"Cormack Scott Daniel","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":13,"first":"2008-09-29","last":"2016-06-15","span_basis":"filed_date"},"name_variants":[{"name":"Cormack Scott Daniel","source":"filing","n_filings":13,"first_seen":"2008-09-29","last_seen":"2016-06-15"}],"transactions":[{"id":2959601,"accession":"0001209191-16-128045","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-128045","line_url":"/filing/0001209191-16-128045#line-3","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001442675","owner_name":"Cormack Scott Daniel","owner_display_name":"Cormack Scott Daniel","owner_url":"/insider/0001442675","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4856.0,"shares_display":"4,856","price_per_share":1.0254,"price_display":"1.03","price_state":"stated","total_value":4979.3424,"total_display":"4,979.34","total_whole":"4,979","shares_owned_after":129428.0,"shares_owned_after_display":"129,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-13","filed_date":"2016-06-15","scope":"insider"},{"id":2316530,"accession":"0001209191-16-108923","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-108923","line_url":"/filing/0001209191-16-108923#line-2","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001442675","owner_name":"Cormack Scott Daniel","owner_display_name":"Cormack Scott Daniel","owner_url":"/insider/0001442675","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12033.0,"shares_display":"12,033","price_per_share":0.83,"price_display":"0.83","price_state":"stated","total_value":9987.39,"total_display":"9,987.39","total_whole":"9,987","shares_owned_after":124909.0,"shares_owned_after_display":"124,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-15","filed_date":"2016-03-16","scope":"insider"},{"id":8720499,"accession":"0001209191-15-053693","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-053693","line_url":"/filing/0001209191-15-053693#line-2","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001442675","owner_name":"Cormack Scott Daniel","owner_display_name":"Cormack Scott Daniel","owner_url":"/insider/0001442675","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4571.0,"shares_display":"4,571","price_per_share":2.69,"price_display":"2.69","price_state":"stated","total_value":12295.99,"total_display":"12,295.99","total_whole":"12,296","shares_owned_after":111942.0,"shares_owned_after_display":"111,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-12","filed_date":"2015-06-16","scope":"insider"},{"id":8793289,"accession":"0001209191-15-045582","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-045582","line_url":"/filing/0001209191-15-045582#line-2","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001442675","owner_name":"Cormack Scott Daniel","owner_display_name":"Cormack Scott Daniel","owner_url":"/insider/0001442675","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7543.0,"shares_display":"7,543","price_per_share":1.88,"price_display":"1.88","price_state":"stated","total_value":14180.84,"total_display":"14,180.84","total_whole":"14,181","shares_owned_after":107138.0,"shares_owned_after_display":"107,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-20","filed_date":"2015-05-21","scope":"insider"},{"id":6322286,"accession":"0001209191-14-052440","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-052440","line_url":"/filing/0001209191-14-052440#line-2","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001442675","owner_name":"Cormack Scott Daniel","owner_display_name":"Cormack Scott Daniel","owner_url":"/insider/0001442675","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18341.0,"shares_display":"18,341","price_per_share":3.17,"price_display":"3.17","price_state":"stated","total_value":58140.97,"total_display":"58,140.97","total_whole":"58,141","shares_owned_after":84139.0,"shares_owned_after_display":"84,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-13","filed_date":"2014-08-14","scope":"insider"},{"id":6703226,"accession":"0001209191-14-021636","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-021636","line_url":"/filing/0001209191-14-021636#line-2","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001442675","owner_name":"Cormack Scott Daniel","owner_display_name":"Cormack Scott Daniel","owner_url":"/insider/0001442675","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4634.0,"shares_display":"4,634","price_per_share":12.25,"price_display":"12.25","price_state":"stated","total_value":56766.5,"total_display":"56,766.50","total_whole":"56,767","shares_owned_after":64980.0,"shares_owned_after_display":"64,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-17","filed_date":"2014-03-18","scope":"insider"},{"id":9268763,"accession":"0001209191-13-047610","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-047610","line_url":"/filing/0001209191-13-047610#line-1","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001442675","owner_name":"Cormack Scott Daniel","owner_display_name":"Cormack Scott Daniel","owner_url":"/insider/0001442675","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3112.0,"shares_display":"3,112","price_per_share":8.68,"price_display":"8.68","price_state":"stated","total_value":27012.16,"total_display":"27,012.16","total_whole":"27,012","shares_owned_after":60238.0,"shares_owned_after_display":"60,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-19","filed_date":"2013-10-07","scope":"insider"},{"id":9268762,"accession":"0001209191-13-047608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-047608","line_url":"/filing/0001209191-13-047608#line-1","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001442675","owner_name":"Cormack Scott Daniel","owner_display_name":"Cormack Scott Daniel","owner_url":"/insider/0001442675","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2134.0,"shares_display":"2,134","price_per_share":11.9,"price_display":"11.90","price_state":"stated","total_value":25394.6,"total_display":"25,394.60","total_whole":"25,395","shares_owned_after":56788.0,"shares_owned_after_display":"56,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-12","filed_date":"2013-10-07","scope":"insider"},{"id":9102589,"accession":"0001209191-11-002346","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-11-002346","line_url":"/filing/0001209191-11-002346","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001442675","owner_name":"Cormack Scott Daniel","owner_display_name":"Cormack Scott Daniel","owner_url":"/insider/0001442675","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.52,"price_display":"16.52","price_state":"stated","total_value":165200.0,"total_display":"165,200.00","total_whole":"165,200","shares_owned_after":13067.0,"shares_owned_after_display":"13,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-04","filed_date":"2011-01-06","scope":"insider","n_lines":2},{"id":7613890,"accession":"0001209191-10-058374","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-058374","line_url":"/filing/0001209191-10-058374#line-2","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001442675","owner_name":"Cormack Scott Daniel","owner_display_name":"Cormack Scott Daniel","owner_url":"/insider/0001442675","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.02,"price_display":"16.02","price_state":"stated","total_value":80100.0,"total_display":"80,100.00","total_whole":"80,100","shares_owned_after":13067.0,"shares_owned_after_display":"13,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-01","filed_date":"2010-12-03","scope":"insider"},{"id":7528973,"accession":"0001209191-10-055500","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-055500","line_url":"/filing/0001209191-10-055500#line-2","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001442675","owner_name":"Cormack Scott Daniel","owner_display_name":"Cormack Scott Daniel","owner_url":"/insider/0001442675","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.99,"price_display":"15.99","price_state":"stated","total_value":79950.0,"total_display":"79,950.00","total_whole":"79,950","shares_owned_after":8092.0,"shares_owned_after_display":"8,092","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-15","filed_date":"2010-11-17","scope":"insider"},{"id":7690650,"accession":"0001209191-10-052709","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-052709","line_url":"/filing/0001209191-10-052709#line-2","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001442675","owner_name":"Cormack Scott Daniel","owner_display_name":"Cormack Scott Daniel","owner_url":"/insider/0001442675","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.45,"price_display":"15.45","price_state":"stated","total_value":77250.0,"total_display":"77,250.00","total_whole":"77,250","shares_owned_after":13067.0,"shares_owned_after_display":"13,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-01","filed_date":"2010-11-02","scope":"insider"},{"id":3970890,"accession":"0001209191-08-053751","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-08-053751","line_url":"/filing/0001209191-08-053751","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001442675","owner_name":"Cormack Scott Daniel","owner_display_name":"Cormack Scott Daniel","owner_url":"/insider/0001442675","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.989,"price_display":"3.99","price_state":"stated","total_value":19945.0,"total_display":"19,945.00","total_whole":"19,945","shares_owned_after":4306.0,"shares_owned_after_display":"4,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-26","filed_date":"2008-09-29","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000949858","name":"ONCOGENEX PHARMACEUTICALS, INC.","url":"/issuer/0000949858","role":"Director, Officer (President and CEO)","n_filings":13,"first_seen":"2008-09-29","last_seen":"2016-06-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001442675","retrieved_at":"2026-08-24T03:07:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}